Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
MTT Shipping chairman Ong Kean Lee acquires MYR 339,000 stake in company shares

MTT Shipping chairman Ong Kean Lee acquires MYR 339,000 stake in company shares

BitgetBitget2026/10/02 09:53
  • MTT Shipping and Logistics’ non-independent executive chairman, Dato’ Seri Ong Kean Lee, made an indirect acquisition of 300,000 ordinary shares.
  • Total consideration was MYR 339,000.
  • The shares represented 0.012% of the company’s issued share capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MTT Shipping and Logistics Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3711685) on October 02, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12